Same-day discharge after coronary angioplasty is increasingly popular but still not the gold standard

Same-Day Discharge After Coronary Angioplasty Is Increasingly Popular But Still Not the Gold StandardThe length of hospital stay after elective coronary angioplasty varies significantly among operators and hospitals, according to a recent survey of interventional cardiologists in the United States (US), Canada, and the United Kingdom (UK), published in Catherization and Cardiovascular Interventions.

 

While same-day discharge is a routine proceeding in the UK, most interventional cardiologists surveyed mentioned that they were not aware of the existence of any guideline featuring criteria differentiating patients that can be safely discharged from those who should stay at least overnight.

 

The most reliable reference available on this subject matter was the expert consensus statement issued by the Society for Cardiovascular Angiography and Interventions  (SCAI), published in 2009. However, advancements in technology and clinical practice in itself have rendered this document obsolete.

 

The current dilemma is the length of observation for patients who have undergone elective coronary angioplasty. Some physicians, based on a mixture of randomized and observational evidence, are convinced that same-day discharge is safe, appropriate, and cost-effective. Others, based on their own criteria, prefer keeping these patients in observation.

 

Nowadays, it seems as if same-day discharge was a routine proceeding in some sites, while others are not even open to that alternative.

 

The wide difference between physicians in the US and those in the UK and Canada is entirely unsurprising. US physicians traditionally favor the transfemoral approach, which constitutes a significant hindrance for same-day discharge.

 

The SCAI expert consensus statement should be updated as regards the length of stay after scheduled coronary angioplasty, taking into account the vast randomized and controlled evidence on the issue published since 2009.

 

A temporary solution till the creation of a supporting document on this subject matter would be to have each institution adopt its own protocol. This would be more beneficial for high-volume operators and institutions.

 

Other variables that should be considered are harder to measure because they are related to each individual patient. His/her ability to understand instructions, his/her social support system, and the distance between the hospital and his/her home are factors that should be taken into account while deciding on the possibility of an early same-day discharge.

 

Conclusion

While there is considerable variation among physicians, most still prefer overnight observation for patients who have undergone a scheduled coronary angioplasty. Current evidence warrants the update of clinical practice guidelines.

 

Editorial

A large randomized study assessing both strategies should be carried out. Until that study is finalized, same-day discharge after angioplasty without complications is a reasonable course of action in selected patients.

 

Theoretically, the aforementioned randomized study needed should include over 17,000 patients in order to have the statistical power to reach a definitive conclusion (given the low frequency of events). The availability of this information in the short term, if ever, seems unlikely.

 

Original title: Variation in practice and concordance with guideline criteria for length of stay after elective percutaneous coronary intervention.

Reference: Din JN et al. Cath Cardiovasc Interv. 2017;Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...